Please join us for this online series of tailored webinars led by a cross-practice team of Morgan Lewis life sciences lawyers. The program is designed to provide Japanese companies with insight into a variety of topics affecting the life sciences industry.
Each session is self-contained, and participants can pick topics of particular interest or relevance or attend the whole series. The webinars are structured for learning in an efficient and convenient format.
CLE credit: CLE credit in CA, CT, FL, IL, NJ (via reciprocity), NY, PA, TX, and VA is currently pending approval.
In this session, partner Michael Barron and associate Sheri Yano will discuss key features of founders' agreements, convertible notes, and SAFEs; whether a founders' agreement makes sense for your company; and whether a convertible note or SAFE makes sense for your company.
Join Tim Corbett, Jacqueline Berman, and Christopher Betti as they discuss public disclosures as a window into the industry and business.
In this session, FDA partners Kathleen Sanzo and Jacqueline Berman will explain how the biopharma industry is using AI to increase efficiencies during the drug development process, explore the legal and regulatory implications of AI’s application to clinical trials, and discuss the potential future of AI in the Food and Drug Administration’s drug and biologic divisions.
Join us as we discuss key FDA policies applicable to artificial intelligence (AI) and machine learning (ML) technologies when intended for healthcare applications.
This session will cover recent trends in the patentability of digital health innovations and the use of artificial intelligence platforms in healthcare: including Medical Imaging and Diagnostics, Advanced Healthcare Biometrics, and Drug Discovery.
From CRISPR-Cas9 to iPSCs and mRNA inhibitors, cell and gene therapies represent the cutting edge of innovation. While this exciting and rapidly developing field continues to revolutionize the pharmaceutical and biotechnology industry, it also presents unique legal and regulatory challenges. Please join us for a discussion of some of the key legal and regulatory issues impacting the cell and gene therapy space.
Please join us for the next installment of the Life Sciences Growth Series, focused on university licensing. This webinar gives an overview of university licensing, what it is, the motivation behind it, and university-specific policies and laws.
Join our London lawyer Paul Ranson for a one-hour webinar to discuss the issues and challenges arising from the growing need for producers to demonstrate value and share risk.
Recent scientific advancements have revolutionized the way food and agricultural products are being grown, sold, and regulated. Partner Robert Hibbert provides an overview of some of these advancements and what these technologies mean for the food/agricultural industry going forward.
In recent years, medical science has become increasingly personal, focusing on matching individual patients to what may be the safest and most effective treatment for them. This webinar covers the current United States personalized medicine landscape, as well as FDA’s laws, regulations, and policies impacting this new and developing product category.
Presentation available upon request.
Over the past year, FDA has continued to issue new guidance documents and policy statements on its regulation of software and other digital health technologies. This webinar provides an update on recent FDA actions and expected future developments.
Presentation available upon request.
This webinar discussed employment law issues affecting emerging life sciences companies, including the importance of having confidentiality and invention assignment agreements, the risks and ramifications of hiring independent contractors vs. employees, employment law considerations when doing business internationally including FCPA compliance, and immigration issues you may face here and abroad.
This session includes a discussion of CFIUS (Committee on Foreign Investment in the United States) national security review issues, export control, sanctions and trade issues, as well as the protection of intellectual property rights, choice and conflicts of law, and dispute resolution.
This webinar provides life sciences-focused startup and early-stage companies a comprehensive overview of FDA and intellectual property topics affecting the life sciences industry.
This webinar guides startup and early-stage companies on the due diligence and preparation needed for a Series A investment.
This webinar focuses on the key commercial agreements that early-stage companies need to set themselves up for success.
This webinar gives an overview of university licensing, what it is, the motivations behind it, and university-specific policies and laws.
This webinar provides advice on making a clean start and avoiding common legal mistakes made by life science entrepreneurs.